Return to CYTE Homepage

Dr Annalisa Jenkins

Annalisa Jenkins, M.B.B.S., F.R.C.P. serves as a member of the Perspectum Ltd. board of directors. Dr Jenkins also serves as Chairman of the court of the London School of Hygiene and Tropical Medicine. Dr Jenkins previously served as the Chief Executive Officer of PlaqueTec Ltd. and was previously the Chief Executive Officer and a member of the board of directors of Dimension Therapeutics, Inc. Dr Jenkins previously served as Executive Vice President, Head of Global Research and Development for Merck Serono Pharmaceuticals. Previously, she served as Merck Serono’s Executive Vice President, Global Development and Medical, and was a member of Merck Serono’s Executive Committee. Prior to that, Dr Jenkins pursued a 15-year career at Bristol-Myers Squibb Company, where she was a Senior Vice President and Head of Global Medical Affairs.

Dr Jenkins is currently a committee member of the science board to the FDA, the Court of the London School of Hygiene and Tropical Medicine and is a non-executive director of Genomics England and AgeX Therapeutics, INC. Dr Jenkins serves on the board of directors of Affimed N.V., AVROBIO, Inc., Compass Pathways plc, Oncimmune.

Dr Jenkins received an M.B.B.S. in medicine from St. Bartholomew’s Hospital at the University of London and subsequently trained in cardiovascular medicine in the UK National Health Service. Earlier in her career, Dr Jenkins served as a medical officer in the British Royal Navy. Dr Jenkins is a Fellow of the Royal College of Physicians in London.

To find out more or request a job description, contact us at

Back to Careers

Join Network